Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001501
Filing Date
2025-01-15
Accepted
2025-01-15 17:04:11
Documents
1
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 form4-01152025_100107.html 4  
1 form4-01152025_100107.xml 4 9309
  Complete submission text file 0001415889-25-001501.txt   10916
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Issuer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address
Schmid John P. (Reporting) CIK: 0001478916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37985 | Film No.: 25533587